High-dose nicotine patch therapy for smokers with a history of alcohol dependence: 36-week outcomes

被引:36
|
作者
Kalman, D [1 ]
Kahler, CW
Garvey, AJ
Monti, PM
机构
[1] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA
[2] Edith Nourse Rogers Mem Vet Adm Med Ctr, Bedford, MA 01730 USA
[3] Brown Univ, Ctr Alcohol & Addict Studies, Providence, RI 02912 USA
[4] Harvard Univ, Sch Dent Med, Boston, MA 02115 USA
[5] Vet Adm Med Ctr, Providence, RI 02908 USA
关键词
nicotine patch; smoking cessation; nicotine dependence; alcohol dependence; addiction;
D O I
10.1016/j.jsat.2006.01.001
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
This study reports findings from an investigation of the efficacy of high-dose nicotine patch (NP) therapy for heavy smokers with a history of alcohol dependence. One hundred thirty participants were randomly assigned to 42 or 21 mg of transdermal nicotine. Follow-up assessments were conducted at 4, 12, 24, and 36 weeks. Differences between dose conditions were nonsignificant, although, unexpectedly, outcomes favored participants in the 21-mg NP condition. Nicotine abstinence rates in the 21- and 42-mg NP conditions on Week 36 follow-up were 16.9% and 9.2%, respectively. Patch condition did not interact with severity of nicotine dependence. However, nicotine abstinence at follow-up was related to a longer length of alcohol abstinence. No evidence was found for better outcomes as a function of the percentage of baseline cotinine replaced by NPs. Future research should focus primarily on investigating ways to improve smoking quit rates for smokers in early alcohol recovery. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:213 / 217
页数:5
相关论文
共 50 条
  • [31] Outcomes of antiemetic therapy after the administration of high-dose antineoplastic agents
    Trovato, JA
    Stull, DM
    Finley, RS
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1998, 55 (12) : 1269 - 1274
  • [32] Incremental efficacy of adding bupropion to the nicotine patch for smoking cessation in smokers with a recent history of alcohol dependence: Results from a randomized, double-blind, placebo-controlled study
    Kalman, David
    Herz, Lawrence
    Monti, Peter
    Kahler, Christopher W.
    Mooney, Marc
    Rodrigues, Stephanie
    O'Connor, Kathryn
    DRUG AND ALCOHOL DEPENDENCE, 2011, 118 (2-3) : 111 - 118
  • [33] The prevalence, predictors and associated health outcomes of high nicotine dependence using three measures among US smokers
    Schnoll, Robert A.
    Goren, Amir
    Annunziata, Kathy
    Suaya, Jose A.
    ADDICTION, 2013, 108 (11) : 1989 - 2000
  • [34] Reduction of abstinence-induced withdrawal and craving using high-dose nicotine replacement therapy
    Shiffman, S
    Ferguson, SG
    Gwaltney, CJ
    Balabanis, MH
    Shadel, WG
    PSYCHOPHARMACOLOGY, 2006, 184 (3-4) : 637 - 644
  • [35] Reduction of abstinence-induced withdrawal and craving using high-dose nicotine replacement therapy
    Saul Shiffman
    Stuart G. Ferguson
    Chad J. Gwaltney
    Mark H. Balabanis
    William G. Shadel
    Psychopharmacology, 2006, 184 : 637 - 644
  • [36] Outcomes of Patients with Alcohol Withdrawal Syndrome Treated with High-Dose Sedatives and Deferred Intubation
    Stewart, Robert
    Perez, Ricardo
    Musial, Bogdan
    Lukens, Carrie
    Adjepong, Yaw Amoateng
    Manthous, Constantine A.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2016, 13 (02) : 248 - 252
  • [37] ONCE-A-WEEK HIGH-DOSE THYROID-HORMONE REPLACEMENT THERAPY IN A HYPOTHYROID PATIENT
    NAAFS, MAB
    FISCHER, HRA
    BENDER, PPM
    SILBERBUSCH, J
    NETHERLANDS JOURNAL OF MEDICINE, 1987, 30 (04): : 187 - 192
  • [38] Gender differences with high-dose naltrexone in patients with co-occurring cocaine and alcohol dependence
    Pettinati, Helen M.
    Kampman, Kyle M.
    Lynch, Kevin G.
    Suh, Jesse J.
    Dackis, Charles A.
    Oslin, David W.
    O'Brien, Charles P.
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2008, 34 (04) : 378 - 390
  • [39] Safety, tolerability, and feasibility of high-dose naltrexone in alcohol dependence: an open-label study
    Yoon, Gihyun
    Kim, Suck Won
    Thuras, Paul
    Westermeyer, Joseph
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2011, 26 (02) : 125 - 132
  • [40] Four-cycle high-dose therapy with hematopoietic support for metastatic breast cancer: No improvement in outcomes compared with single-course high-dose therapy
    Hu, WW
    Negrin, RS
    Stockerl-Goldstein, K
    Johnston, LJ
    Shizuru, JA
    Wong, RM
    Chao, NJ
    Long, GD
    Feiner, RH
    Blume, KG
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2000, 6 (01) : 58 - 69